'Immunogenicity' diaporamas de présentation

Fundamentals of Acquired Immunity

1.4k views • 96 slides

Chapter 4 Antigen

Chapter 4 Antigen. Definitions of antigen Antigen : non-self substances which can combine with TCR or BCR or Ab and have the potential of inducing immune response . Antigen: Tolerogen: an antigen that induces immunological tolerance

1.02k views • 55 slides

Meningococcal A,C,Y,W135 Conjugate Vaccine (Menactra TM )

Aventis Pasteur, Inc. Meningococcal A,C,Y,W135 Conjugate Vaccine (Menactra TM ). Lucia H. Lee CBER, FDA. Vaccines and Related Biological Products Advisory Committee Meeting September 22, 2004. Outline. Proposed Basis for Licensure: 11-55 years old Clinical Studies

802 views • 48 slides

H5N1 Pediatric Experience

H5N1 Pediatric Experience. A Randomized, Double-blinded, Placebo-controlled, Phase I/II, Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine In Healthy Children Aged 2 Years Through 9 Years (DMID 04-077)

580 views • 43 slides

Combined paediatric vaccines for national immunization programmes

626 views • 42 slides

General considerations for clinical trials of vaccines

General considerations for clinical trials of vaccines. Ming-Hsiao Chan, MD,MPH Researcher/Team Leader, Division of Clinical Sciences, Center for Drug Evaluation, Taiwan. Disclaimer.

763 views • 42 slides

Licensure of Pandemic Influenza Vaccines: Demonstration of Effectiveness

Licensure of Pandemic Influenza Vaccines: Demonstration of Effectiveness. Vaccines and Related Biological Products Advisory Committee Meeting February 29, 2012. Theresa M. Finn, OVRR, CBER, FDA. Outline. Background Pandemic influenza Pandemic Planning 2007 Guidance for Industry

683 views • 38 slides

Clinical Evaluation of Preventive Vaccines: Use of Bridging Studies

Clinical Evaluation of Preventive Vaccines: Use of Bridging Studies. Marion F. Gruber, Ph.D. 2006 FDA/Industry Statistics Workshop Washington D.C., September 29, 2006. Objectives. Approval Process for Preventive Vaccines Applicable laws & regulations Clinical endpoint efficacy studies

655 views • 36 slides

Outline

557 views • 32 slides

Basic Principles of Immunohematology

Basic Principles of Immunohematology. Teaching Aims. To understand the basis of Immunology and genetics which are closely involved in the understanding of blood group serology. Antigen and Antibody. Antigen:

6.13k views • 28 slides

Helen Fletcher, PhD Senior Lecturer in Immunology, London School of Hygiene and Tropical Medicine

The MVA85A Phase IIb study in South African infants- what can we learn from this TB vaccine efficacy trial?. Helen Fletcher, PhD Senior Lecturer in Immunology, London School of Hygiene and Tropical Medicine. Why is TB vaccine development so difficult?. Rappuloi and Aderem, Nature 2012.

458 views • 26 slides

Antigens

Antigens. Dr. Conrad Sept. 4, 2009. ANTIGENS Objectives: At the end of the lecture students will be able to:

463 views • 23 slides

Statistical Comparison of Immunogenicity Cutpoint Factors Using Log Transformation

Statistical Comparison of Immunogenicity Cutpoint Factors Using Log Transformation. Dingzhou (Dean) Li PharmaTx Statistics, Pfizer Global R&D MBSW, 2010. Definitions. Immunogenicity: Causing or capable of producing an immune response. Unwanted for target-binding drugs

950 views • 22 slides

Antigens

Antigens. Jennifer Nyland, PhD Office: Bldg#1, Room B10 Phone: 733-1586 Email: jnyland@uscmed.sc.edu. Teaching objectives. To compare and contrast immunogen , antigen & hapten To describe the factors influencing immunogenicity To define the chemical nature of immunogens

587 views • 19 slides

Antigens

Antigens. Jennifer Nyland, PhD Office: Bldg#1, Room B10 Phone: 733-1586 Email: jnyland@uscmed.sc.edu. Teaching objectives. To compare and contrast immunogen , antigen & hapten To describe the factors influencing immunogenicity To define the chemical nature of immunogens

222 views • 19 slides

Immunogenicity Overview of Therapeutic Biologics

178 views • 11 slides

Immunogenicity overview of therapeutic biologics

Immunogenicity overview of therapeutic biologics

220 views • 11 slides

Diagnostic of infectious diseases

Diagnostic of infectious diseases. Direct diagnostic . Visualisation -microscopy -antigen detection -cultivation -genetic matierial detection Indirect diagnostic: - detection of the reaction of macroorganism to the presence of microorganism Specific reaction of immune system

562 views • 9 slides

H Liu et al. Nature 000 , 1-4 (2014) doi:10.1038/nature12978

Amph-vaccines maximize the immunogenicity and therapeutic efficacy of polypeptide vaccines. H Liu et al. Nature 000 , 1-4 (2014) doi:10.1038/nature12978.

106 views • 1 slides

SENDAI Protocol

SENDAI Protocol

138 views • 1 slides